Insider Buying: Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Director Acquires 1,000 Shares of Stock

Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Director Catherine Cusack acquired 1,000 shares of the company’s stock in a transaction dated Friday, February 21st. The stock was acquired at an average cost of $16.43 per share, for a total transaction of $16,430.00. Following the completion of the acquisition, the director now directly owns 59,083 shares in the company, valued at approximately $970,733.69. The trade was a 1.72 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this hyperlink.

Catherine Cusack also recently made the following trade(s):

• On Monday, February 24th, Catherine Cusack bought 1,500 shares of Sabra Health Care REIT stock. The stock was bought at an average price of $15.92 per share, for a total transaction of $23,880.00.

Sabra Health Care REIT Price Performance

Shares of SBRA opened at $16.42 on Wednesday. Sabra Health Care REIT, Inc. has a 1-year low of $13.31 and a 1-year high of $20.03. The stock has a market cap of $3.91 billion, a PE ratio of 30.98, a P/E/G ratio of 1.97 and a beta of 1.25. The firm has a 50-day simple moving average of $16.79 and a two-hundred day simple moving average of $17.63. The company has a debt-to-equity ratio of 0.88, a current ratio of 4.32 and a quick ratio of 4.16.

Sabra Health Care REIT (NASDAQ:SBRA) last announced its quarterly earnings results on Wednesday, February 19th. The real estate investment trust reported $0.36 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.36. The business had revenue of $182.35 million during the quarter, compared to analysts’ expectations of $178.01 million. Sabra Health Care REIT had a net margin of 18.02% and a return on equity of 4.60%. As a group, analysts forecast that Sabra Health Care REIT, Inc. will post 1.45 EPS for the current year.

Sabra Health Care REIT Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 28th. Investors of record on Friday, February 14th will be issued a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a dividend yield of 7.31%. The ex-dividend date of this dividend is Friday, February 14th. Sabra Health Care REIT’s dividend payout ratio (DPR) is currently 226.42%.

Wall Street Analysts Forecast Growth

SBRA has been the topic of several research reports. Citizens Jmp raised shares of Sabra Health Care REIT from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, January 7th. JMP Securities raised shares of Sabra Health Care REIT from a “market perform” rating to an “outperform” rating and set a $20.00 target price on the stock in a research note on Tuesday, January 7th. Mizuho reaffirmed a “neutral” rating and set a $20.00 target price on shares of Sabra Health Care REIT in a research note on Thursday, December 5th. Finally, Truist Financial downgraded shares of Sabra Health Care REIT from a “buy” rating to a “hold” rating and reduced their target price for the stock from $18.00 to $17.00 in a research note on Friday, January 17th. Three analysts have rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, Sabra Health Care REIT presently has an average rating of “Moderate Buy” and a consensus price target of $18.86.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the business. Geode Capital Management LLC lifted its position in shares of Sabra Health Care REIT by 1.7% during the 3rd quarter. Geode Capital Management LLC now owns 6,294,798 shares of the real estate investment trust’s stock worth $117,165,000 after buying an additional 104,533 shares during the last quarter. JPMorgan Chase & Co. lifted its position in shares of Sabra Health Care REIT by 222.4% during the 3rd quarter. JPMorgan Chase & Co. now owns 9,886,917 shares of the real estate investment trust’s stock worth $183,996,000 after buying an additional 6,819,919 shares during the last quarter. Vestcor Inc lifted its position in shares of Sabra Health Care REIT by 62.5% during the 3rd quarter. Vestcor Inc now owns 207,918 shares of the real estate investment trust’s stock worth $3,869,000 after buying an additional 79,956 shares during the last quarter. Barclays PLC lifted its position in shares of Sabra Health Care REIT by 56.1% during the 3rd quarter. Barclays PLC now owns 678,397 shares of the real estate investment trust’s stock worth $12,624,000 after buying an additional 243,895 shares during the last quarter. Finally, Franklin Resources Inc. lifted its position in shares of Sabra Health Care REIT by 12.3% during the 3rd quarter. Franklin Resources Inc. now owns 524,917 shares of the real estate investment trust’s stock worth $9,543,000 after buying an additional 57,551 shares during the last quarter. Institutional investors and hedge funds own 99.40% of the company’s stock.

About Sabra Health Care REIT

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.